444 related articles for article (PubMed ID: 12746913)
1. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
De Benedetti F; Meazza C; Vivarelli M; Rossi F; Pistorio A; Lamb R; Lunt M; Thomson W; Ravelli A; Donn R; Martini A;
Arthritis Rheum; 2003 May; 48(5):1398-407. PubMed ID: 12746913
[TBL] [Abstract][Full Text] [Related]
2. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.
Donn R; Alourfi Z; De Benedetti F; Meazza C; Zeggini E; Lunt M; Stevens A; Shelley E; Lamb R; Ollier WE; Thomson W; Ray D;
Arthritis Rheum; 2002 Sep; 46(9):2402-9. PubMed ID: 12355488
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis.
Meazza C; Travaglino P; Pignatti P; Magni-Manzoni S; Ravelli A; Martini A; De Benedetti F
Arthritis Rheum; 2002 Jan; 46(1):232-7. PubMed ID: 11817596
[TBL] [Abstract][Full Text] [Related]
4. A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis.
Donn RP; Shelley E; Ollier WE; Thomson W;
Arthritis Rheum; 2001 Aug; 44(8):1782-5. PubMed ID: 11508429
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids.
Vivarelli M; D'Urbano LE; Insalaco A; Lunt M; Jury F; Tozzi AE; Ravelli A; Martini A; Donn R; De Benedetti F
Clin Exp Rheumatol; 2007; 25(5):775-81. PubMed ID: 18078632
[TBL] [Abstract][Full Text] [Related]
6. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
[TBL] [Abstract][Full Text] [Related]
7. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis.
Donn R; Alourfi Z; Zeggini E; Lamb R; Jury F; Lunt M; Meazza C; De Benedetti F; Thomson W; Ray D;
Arthritis Rheum; 2004 May; 50(5):1604-10. PubMed ID: 15146431
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
[TBL] [Abstract][Full Text] [Related]
9. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
10. The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families.
Ogilvie EM; Fife MS; Thompson SD; Twine N; Tsoras M; Moroldo M; Fisher SA; Lewis CM; Prieur AM; Glass DN; Woo P
Arthritis Rheum; 2003 Nov; 48(11):3202-6. PubMed ID: 14613283
[TBL] [Abstract][Full Text] [Related]
11. Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis.
Berdeli A; Ozyürek AR; Ulger Z; Gürses D; Levent E; Salar K; Gürpinar AR
Rheumatol Int; 2006 Jun; 26(8):726-31. PubMed ID: 16220288
[TBL] [Abstract][Full Text] [Related]
12. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.
Oen K; Tucker L; Huber AM; Miettunen P; Scuccimarri R; Campillo S; Cabral DA; Feldman BM; Tse S; Chédeville G; Spiegel L; Schneider R; Lang B; Ellsworth J; Ramsey S; Dancey P; Silverman E; Chetaille AL; Cameron B; Johnson N; Dorval J; Petty RE; Duffy KW; Boire G; Haddad E; Houghton K; Saint-Cyr C; Turvey SE; Benseler S; Cheang M; Yeung RS; Duffy CM
Arthritis Rheum; 2009 Aug; 61(8):1077-86. PubMed ID: 19644903
[TBL] [Abstract][Full Text] [Related]
13. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study.
Spiegel LR; Schneider R; Lang BA; Birdi N; Silverman ED; Laxer RM; Stephens D; Feldman BM
Arthritis Rheum; 2000 Nov; 43(11):2402-9. PubMed ID: 11083261
[TBL] [Abstract][Full Text] [Related]
14. A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass.
Lehmann LE; Schroeder S; Hartmann W; Dewald O; Book M; Weber SU; Schewe JC; Stüber F
Eur J Cardiothorac Surg; 2006 Jul; 30(1):59-63. PubMed ID: 16527487
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis.
Amoli MM; Garcia-Porrua C; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2005 Jan; 32(1):74-6. PubMed ID: 15630728
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.
Ravelli A; Manzoni SM; Viola S; Pistorio A; Ruperto N; Martini A
J Rheumatol; 2001 Sep; 28(9):2100-2. PubMed ID: 11550981
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility.
Martínez A; Orozco G; Varadé J; Sánchez López M; Pascual D; Balsa A; García A; de la Concha EG; Fernández-Gutiérrez B; Martín J; Urcelay E
Hum Immunol; 2007 Sep; 68(9):744-7. PubMed ID: 17869648
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?
Masi L; Simonini G; Piscitelli E; Del Monte F; Giani T; Cimaz R; Vierucci S; Brandi ML; Falcini F
J Rheumatol; 2004 May; 31(5):986-91. PubMed ID: 15124262
[TBL] [Abstract][Full Text] [Related]
19. Serum macrophage migration inhibitory factor (MIF) in the intercritical phase of hereditary periodic fevers and its relationship with the MIF-173G/C polymorphism.
Rigante D; Flex A; Federico G; Pola R; Candelli M; Manna R; Pugliese AL; Cerquaglia C; Compagnone A; Stabile A
Scand J Rheumatol; 2007; 36(4):307-10. PubMed ID: 17763209
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.
Radstake TR; Fransen J; Toonen EJ; Coenen MJ; Eijsbouts AE; Donn R; van den Hoogen FH; van Riel PL
Ann Rheum Dis; 2007 Nov; 66(11):1525-30. PubMed ID: 17456524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
